Phosphodiesterase inhibitors: Knockout drops?

Journal of Pharmacy and Pharmacology

Volumn 49, Issue SUPPL. 3, 1997, Pages 19-24

  Raeburn, David ^a   Karlsson, Jan Anders ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [3 (CYCLOPENTYLOXY) 4 METHOXYPHENYL] 2 PHENYLETHYL]PYRIDINE; BENAFENTRINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CYCLIC AMP; CYCLIC GMP; ENOXIMONE; METHYLXANTHINE; MUSCARINIC RECEPTOR BLOCKING AGENT; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PICLAMILAST; ROLIPRAM; SIGUAZODAN; THEOPHYLLINE; TIBENELAST; TOLAFENTRINE; UNCLASSIFIED DRUG; ZAPRINAST; ZARDAVERINE;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; BRONCHUS MUSCLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG TOXICITY; ENZYME INHIBITION; HUMAN; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAST CELL DEGRANULATION; NAUSEA; ORAL DRUG ADMINISTRATION; VOMITING;

ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; HUMANS; ISOENZYMES; PHOSPHODIESTERASE INHIBITORS;

EID: 0030906162     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Barnes, P. J. (1992) New drugs for asthma. Eur. Respir. J. 5: 1126-1136
2. Barnes, P. J. (1995) Cyclic nucleotides and phosphodiesterases and airway function. Eur. Respir. J. 8: 457-462
3. British Thoracic Society (1993) Guidelines on the management of asthma. Chronic asthma in adults and children. Thorax 48 (Suppl.): S3-S11
4. Brunee, T., Engelstatter, R., Steinijans, V. W., Kunkel, G. (1992) Bronchodilatory effect of inhaled zardaverine, a phosphodiesterase III and IV inhibitor, in patients with asthma. Eur. Respir. J. 5: 982-985
5. Evans, D. J., Aikman, S. L., Kharitonov, S. A., O'Connor, B. J. (1996) Inhaled tolafentrine, a PDE III/IV inhibitor: acute effect on histamine- and AMP-induced bronchoconstriction and exhaled NO in mild asthma. Am. J. Respir. Crit. Care Med. 153: A347
6. Foster, R. W., Rakshi, K., Carpenter, J. R., Small, R. C. (1992) Trials of the bronchodilator activity of the isoenzyme-selective phosphodiesterase inhibitor AH 21-132 in healthy volunteers during a methacholine challenge test. Br. J. Clin. Pharmacol. 34: 527-534
7. Giembycz, M. A., Raeburn, D. (1991) Putative substrates for cyclic nucleotide-dependent protein kinases and the control of airway smooth muscle tone. J. Auton. Pharmacol. 11: 365-398
8. Harbinson, P. L., Sullivan, P. J., Wahid, S., Kilfeather, S., Page, C., Heath, P., Costello, J. F. (1996) Effect of CDP840, a selective inhibitor of phosphodiesterase type IV (PDE IV), on the allergen-induced asthmatic response. Am. J. Respir. Crit. Care Med. 153: A347
9. Hawksworth, R., Heath, P., Lee, T. H. (1996) The effects of single doses of CDP840, a potent and selective phosphodiesterase type IV (PDE IV) inhibitor, on FEV1 in patients with bronchial asthma. Am. J. Respir. Crit. Care Med. 153: A347
10. Heaslip, R. J., Buckley, S. K., Sickels, B. D., Grimes, D. (1991) Bronchial vs cardiovascular activities of selective phosphodiesterase inhibitors in the anesthetized β-blocked dog. J. Pharmacol. Exp. Ther. 257: 741-747
11. Howell, R. E., Sickels, B. D., Woeppel, S. L. (1992) Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs. J. Pharmacol. Exp. Ther. 264: 609-615
12. Israel, E., Mathur, P. N., Tashkin, D., Drazen, J. M. (1988) LY 186655 prevents bronchospasm in asthma of moderate severity. Chest 94 (Suppl.): 71S
13. Karlsson, J.-A., Souness, J., Raeburn, D., Palfreyman, M., Ashton, M. (1993) Anti-inflammatory effects of novel selective cyclic nucleotide phosphodiesterase inhibitors. In: Jolles, G., Karlsson, J.-A., Taylor, J. (eds) T-Lymphocyte and Inflammatory Cell Research in Asthma. Academic Press, London, pp 323-351
14. Kawasaki, A., Hoshino, K., Osaki, R., Mizushima, Y., Yano, S. (1992) Effect of ibudilast: a novel antiasthmatic agent, on airway hypersensitivity in bronchial asthma. J. Asthma 29: 245-252
15. Leeman, M., Lejeune, P., Melot, C., Naeije, R. (1987) Reduction in pulmonary hypertension and in airway resistances by enoximone (MDL 17,043) in decompensated COPD. Chest 91: 662-666
16. MacLeod, D., O'Toole, S., Heath, P., Holgate, S. (1996) Evaluation of the safety and protection against histamine of a new selective phosphodiesterase type IV inhibitor, CDP840 in mild asthma. Am. J. Respir. Crit. Care Med. 153: A347
17. Muller, T., Engels, P., Fozard, J. R. (1996) Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition. Trends Pharmacol. Sci. 17: 294-298
18. Persson, C. G. A. (1986) Overview of effects of theophylline. J. Allergy Clin. Immunol. 78: 780-787
19. Raeburn, D., Advenier, C. (1995) Isoenzyme-selective phosphodiesterase inhibitors: effect on airways smooth muscle. Int. J. Biochem. Cell. Biol. 27: 29-37
20. Raeburn, D., Karlsson, J.-A. (1993) Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo. J. Pharmacol. Exp. Ther. 267: 1147-1152
21. Raeburn, D., Underwood, S. L., Lewis, S. A., Woodman, V. R., Battram, C. H., Tomkinson, A., Sharma, S., Jordan, R., Souness, J. E., Webber, S. E., Karlsson, J.-A. (1994) Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br. J. Pharmacol. 113: 1423-1431
22. Rudd, R. M., Gellert, A. R., Studdy, P. R., Geddes, D. M. (1983) Inhibition of exercise-induced asthma by an orally absorbed mast cell stabilizer (M&B 22,948). Br. J. Dis. Chest 77: 78-86
23. Souness, J. E., Giembycz, M. A. (1994) Cyclic nucleotide phosphodiesterases in airways smooth muscle. In: Raeburn, D., Giembycz, M. A. (eds) Airways Smooth Muscle: Biochemical Control of Contraction and Relaxation. Birkhauser Verlag, Basel, pp 271-308
24. Souness, J. E., Scott, L. C., Tomkinson, A., Giembycz, M. A., Raeburn, D. (1993) Inhibition of cyclic nucleotide phosphodiesterase by ibudilast: comparison with rolipram. Br. J. Pharmacol. 108: 71P
25. Souness, J. E., Raeburn, D., Karlsson, J.-A. (1997) Phosphodiesterase type 4 inhibitors as potential anti-asthma agents. In: Pauwels, R., Advenier, C., O'Byrne, P. (eds) Progress in Basic and Clinical Pharmacology (Antiasthmatic Drugs) In press
26. Sullivan, P., Bekir, S., Jaffar, Z., Page C., Jeffrey P., Costello, J. (1994) Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 343: 1006-1008
27. Torphy, T. J., Undem, B. J. (1991) Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 46: 512-523
28. Ukena, D., Rentz, K., Reiber, C., Sybrecht, G. W. (1995) Effects of the mixed phosphodiesterase III/IV inhibitor, zardavarine, on airway function in patients with chronic airflow obstruction. Respir. Med. 89: 441-444
29. Underwood, D. C., Osborn, R. R., Novak, L. B., Mathews, J. K., Newsholme, S. J., Undem, B. J., Hand, J. M., Torphy, T. J. (1993) Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. J. Pharmacol. Exp. Ther. 266: 306-313
30. Ward, A. J. M., McKenniff, M., Evans, J. M., Page, C. P., Costello, J. F. (1993) Theophylline - an immunomodulatory role in asthma? Am. Rev. Respir. Dis. 147: 518-523